Insmed Inc. buy Rothschild Redb
Start price
06.12.25
/
50%
€177.00
Target price
06.12.26
-
Performance (%)
-23.16%
Price
26.01.26
€129.00
Summary
This prediction is currently active. The prediction for Insmed Inc. disappoints with a performance of -23.16%. This prediction currently runs until 06.12.26. The prediction end date can be changed by Rothschild_Redb at any time. Rothschild_Redb has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Insmed Inc. | -4.412% | -4.412% |
| iShares Core DAX® | -0.121% | 2.507% |
| iShares Nasdaq 100 | 0.081% | -0.241% |
| iShares Nikkei 225® | -1.748% | 4.105% |
| iShares S&P 500 | -0.961% | -0.143% |
Comments by Rothschild_Redb for this prediction
In the thread Insmed Inc. diskutieren
Insmed (NASDAQ:INSM) was upgraded by analysts at Rothschild Redb to a "strong-buy" rating.
Ratings data for INSM provided by MarketBeat